OptraSCAN and Inspirata Announce Their Technical Partnership to Strengthen Digital Pathology Adoption
"We are excited to be working with Inspirata to support their mission to digitize and automate the entire oncologic pathology workflow," said Abhi Gholap, Founder of OptraSCAN. "Our On-Demand scanning model will allow pathologists to digitize their slides without any capital cost," he further added.
OptraSCAN's partnership with Inspirata marks the latest extension to its affordable pay-per-use scanning devices. Shared Inspirata and OptraSCAN customers can now utilize native OptraSCAN image files from within Dynamyx™. Facilitating slide digitization at an affordable cost, the seamless integration of OptraSCAN provides:
• Cloud-based whole slide imaging systems.
• Flexibility to choose from 15 slides capacity to 480 slides capacity.
• Well-equipped for confocal, brightfield, fluorescence, and frozen section applications.
"Inspirata is delighted to work with its friends at OptraSCAN to accelerate global adoption of digital pathology. OptraSCAN's status as an approved partner guarantees the seamless integration of its leading whole slide image scanners with Inspirata's Dynamyx™ digital pathology workflow software," said Dr Mark Lloyd, Founder and EVP, Inspirata.
“Following our recent successes with Inspirata’s Dynamyx™ digital pathology workflow software in Europe, Fujifilm welcomes this partnership between Inspirata and OptraSCAN,” said Tim Wing, Head of Digital Pathology at Fujifilm Europe. “The OptraSCAN range fits small low volume specialist labs all the way up to high volume multi-site labs and will further increase the options for customers of the Fujifilm Digital Pathology Solution looking to make informed choices regarding scanners that fit their often-unique requirements. OptraSCAN’s digital pathology scanners paired with Inspirata’s open-architecture Dynamyx™ case management platform will allow pathologists to implement digital pathology solutions at economical pricing and enable healthcare providers to arrive at their preferred blend of laboratory and diagnostic technologies.”
For more information visit: https://www.optrascan.com/
OptraSCAN® whole slide scanners are CE marked for IVD use.
OptraSCAN® is an ISO13485 certified company.
About Inspirata, Inc.
Inspirata helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.
Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. To learn more visit www.inspirata.com.
Dynamyx is CE marked for IVD use.
Dynamyx is USFDA 510(k) pending.
Senior Product Manager
Tel: +91.20.66540900 x 231
Vice President of Corporate and Digital Marketing
Tel: +1 813-467-7616
1798 Technology Drive, Suite 244, San Jose, CA 95110, USA.
OptraSCAN® are pioneers in the On-Demand Digital Pathology® System, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. OptraSCAN is working to eliminate the barriers to "Go Digital" no matter the size of the pathology lab, the lab's throughput, or global location.
OptraSCAN's end-to-end digital pathology solution provides effective acquisition of whole slide images, viewing, storing, real-time sharing, reporting, and AI & ML based Image analysis solutions via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter.
OptraSCAN Systems are for research use only in North America.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release OptraSCAN and Inspirata Announce Their Technical Partnership to Strengthen Digital Pathology Adoption here
News-ID: 2456660 • Views: 226
More Releases from OptraSCAN Inc
Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Pers …
OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the high-performance OptraSCAN Digital pathology platform to enhance care for their patient population. The capabilities of this digital pathology platform improve accessibility to healthcare and the distributed care model. The demand for digital pathology has increased as healthcare institutions have struggled to overcome the challenges of the traditional care model of pathologists working in labs
OptraSCAN® receives CE-IVDR for OS-Ultra™ high-performance Digital Pathology …
SAN JOSE, Calif., July 28, 2022 / -- OptraSCAN® a leading end-to-end digital pathology solution provider, announced that it has received CE-IVDR marking for the OS-Ultra™ scanners, its high-performance product line of brightfield scanners at an extremely affordable price point, including pay-per-scan based OPEX models. OS Ultra™ scanners have a loading capacity of 80 to 480 slides. With no-touch continuous loading, it scans tissues or cells with a 15 mm x
OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Gr …
SAN JOSE, Calif., May 24, 2022 -- OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned image along with analyzed output as an overlay during
OptraSCAN Announces CytoSiA – A Complete Digital Solution For Scanning And Ana …
San Jose, California – OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening and detection of cervical cancer, pre-cancerous lesions, atypical cells, and all other cytologic categories.
More Releases for Inspirata
Digital Pathology Market - Estimated To Experience A Hike In Growth By 2031 | Mi …
New York, According to a new market research report published by Global Insight Services Digital Pathology Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Digital pathology
Clinical Data Analytics in Healthcare Market May Set New Growth Story | Inspirat …
A Latest intelligence report published by AMA Research with title "Clinical Data Analytics in Healthcare Market Outlook to 2026. A detailed study accumulated to offer Latest insights about acute features of the Global Clinical Data Analytics in Healthcare Market. This report provides a detailed overview of key factors in the Clinical Data Analytics in Healthcare Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology
Whole Slide Imaging Market 2027 Top Players- 3DHISTECH Ltd., Hamamatsu Photonics …
According to our latest study on “Whole Slide Imaging Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. The report highlights trends prevailing in the global whole slide imaging market,
Oncology Informatics Market Emerging Trends and Witness Outstanding Growth by 20 …
The research report on the Oncology Informatics Market provides professional in-depth analysis available on the market status and development trends, including growth rate, competition landscape, opportunities, technological advancement, value chain optimization, drivers, restraints, product launches, future products, area marketplace expanding and the dynamic structure of the market. Further, it provides detailed insight into the Oncology Informatics Market key players that includes their financial statements along with its key development product
Whole Slide Imaging (WSI) Market Boosting the growth | Leading Key Players: Leic …
A new independent 100 page research with title 'Global Whole Slide Imaging (WSI) Market (2018 - 2023)' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes important players/vendors such as Ventana Medical Systems, (Roche), Leica Biosystems, Philips Healthcare, Inspirata (GE Healthcare), Olympus Corporation, Hamamatsu Photonics K.K., DHISTECH, Huron Digital Pathology Inc, Omnyx LLC, Visiopharm A/S etc With n-number of tables and figures examining
Digital Pathology Market Growth With Respect To Application And key players : Ve …
Digital pathology is the use of computer technology to convert analog microscopic images into digital images. It is also known as digital imaging, virtual slides, or virtual microscopy. In other words, it is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed on a computer screen. With the introduction mod whole slide imaging, this technology has been regarded as the most promising method